Watcharananan, Y. and Kurathong, S. 2022. Effects of dapagliflozin on vascular calcification among patients with chronic kidney disease without diabetes: a randomized controlled trial. Journal of the Nephrology Society of Thailand. 27, 2 (Jan. 2022), 57–68.